State Street
JBIO

State Street’s Jade Biosciences JBIO Stock Holding History

State Street’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.21M Buy
655,690
+12,769
+2% +$185K ﹤0.01% 2659
2025
Q4 		$9.92M Buy
642,921
+143,634
+29% +$1.68M ﹤0.01% 2656
2025
Q3 		$4.31M Buy
499,287
+180,516
+57% +$1.48M ﹤0.01% 3049
2025
Q2 		$3.18M Buy
318,771
+308,241
+2,927% +$10.5M ﹤0.01% 3131
2025
Q1 		$925K Sell
10,530
-195
-2% -$17.1K ﹤0.01% 3445
2024
Q4 		$995K Buy
10,725
+226
+2% +$19.5K ﹤0.01% 3491
2024
Q3 		$768K Buy
10,499
+751
+8% +$48.4K ﹤0.01% 3523
2024
Q2 		$566K Buy
9,748
+3,177
+48% +$2.11M ﹤0.01% 3552
2024
Q1 		$6.8M Buy
6,571
+456
+7% +$348K ﹤0.01% 2791
2023
Q4 		$4.84M Buy
6,115
+929
+18% +$473K ﹤0.01% 2956
2023
Q3 		$2.46M Sell
5,186
-210
-4% -$114K ﹤0.01% 3239
2023
Q2 		$3.24M Buy
5,396
+122
+2% +$78K ﹤0.01% 3198
2023
Q1 		$3.72M Sell
5,274
-217
-4% -$180K ﹤0.01% 3104
2022
Q4 		$5.63M Buy
5,491
+543
+11% +$394K ﹤0.01% 2990
2022
Q3 		$2.87M Sell
4,948
-154
-3% -$103K ﹤0.01% 3303
2022
Q2 		$2.79M Buy
5,102
+301
+6% +$144K ﹤0.01% 3367
2022
Q1 		$3.08M Buy
4,801
+395
+9% +$153K ﹤0.01% 3402
2021
Q4 		$1.82M Buy
4,406
+810
+23% +$410K ﹤0.01% 3666
2021
Q3 		$2.64M Buy
+3,596
New +$2.01M ﹤0.01% 3536

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street's JBIO Position: Q1 2026 in Review

State Street increased its Jade Biosciences (JBIO) stake by 2% in Q1 2026, buying an estimated $185K and bringing the position to 655,690 shares worth $9.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2659.

State Street first reported a position in JBIO in Q3 2021 and has held it in 19 quarters since. The position peaked at $9.92M in Q4 2025. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • State Street held 655,690 shares of Jade Biosciences worth $9.21M as of Q1 2026.
  • State Street bought 12,769 Jade Biosciences shares in Q1 2026, an estimated $185K.
  • Jade Biosciences made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2659 holding.
  • State Street first reported a position in Jade Biosciences in Q3 2021 and has held it in 19 quarters since.
  • State Street's Jade Biosciences position peaked at $9.92M in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.